First positive doping test at Paris Olympics is Iraqi judoka

First positive doping test at Paris Olympics is Iraqi judoka

/ 11:41 PM July 26, 2024

Paris Olympics 2024 where to watch ONE Sports channels paris France

FILE–The Eiffel Tower is seen behind a Paris Olympics canvas, from the Trocadero plaza Thursday, July 18, 2024 in Paris. (AP Photo/David Goldman)

PARIS— A male judoka from Iraq tested positive for two anabolic steroids at the Paris Olympics, the International Testing Agency said Friday.

Sajjad Sehen, a 28-year-old first-time Olympian, tested positive for metandienone and boldenone in a sample taken in Paris on Tuesday. He was due to compete next Tuesday.

Article continues after this advertisement

READ: Increased drug testing for China swim team before Paris Olympics

FEATURED STORIES

Sehen is provisionally suspended while a disciplinary case is prosecuted, said the ITA, which oversees the games-time anti-doping program for the International Olympic Committee.

“This means that the athlete is prevented from competing, training, coaching, or participating in any activity during the Olympic Games,” the agency said.

Article continues after this advertisement

Sehen was due to compete in the men’s 81 kilogram class, starting Tuesday in the round of 32 against an opponent from Uzbekistan.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

Follow Inquirer Sports’ special coverage of the Paris Olympics 2024.

TAGS: Paris Olympics

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.